Find stats on top websites
Industry Landscape
The cognitive enhancement market is experiencing robust growth driven by increasing consumer awareness of brain health and a desire for improved mental performance. Innovation in nootropic formulations and personalized approaches are key trends, but the industry faces challenges related to regulatory scrutiny and skepticism regarding efficacy claims. Competition is intense with new players constantly entering the market.
Total Assets Under Management (AUM)
Cognitive Enhancers Market Size in United States
~3.2 Billion USD (2022)
(8.5% CAGR)
- Driven by increasing adoption of nootropics.
- Growing awareness of brain health benefits.
- Demand from students and working professionals.
Total Addressable Market
5.3 Billion USD
Market Growth Stage
Pace of Market Growth
Emerging Technologies
Personalized Nootropic Stacks
Leveraging AI and genetic data to create bespoke nootropic formulations tailored to individual neurochemistry and goals.
Neurofeedback & Brain-Computer Interfaces (BCI)
Technologies allowing direct brain activity measurement and modulation to enhance cognitive function, potentially integrating with supplement use.
CRISPR Gene Editing for Cognitive Enhancement
Although nascent and highly controversial, gene editing could someday offer permanent cognitive enhancements by altering genetic predispositions.
Impactful Policy Frameworks
FDA's Guidance for Industry: New Dietary Ingredient Notifications and Related Issues (2016, ongoing updates)
This guidance outlines the regulatory framework for new dietary ingredients (NDIs) in the U.S., requiring manufacturers to demonstrate the safety of ingredients not marketed in the U.S. before October 15, 1994.
This policy directly impacts CompanionLabs by requiring rigorous safety substantiation for any new or novel ingredients used in their nootropic formulations, potentially increasing R&D costs and time to market.
Federal Trade Commission (FTC) Act Section 5 (ongoing enforcement)
Section 5 of the FTC Act prohibits unfair methods of competition and unfair or deceptive acts or practices in commerce, particularly focusing on advertising and marketing claims for supplements.
CompanionLabs must ensure all marketing and advertising claims for their cognitive enhancement products are truthful, non-misleading, and substantiated by competent and reliable scientific evidence, or face potential enforcement actions and penalties.
California Proposition 65 (The Safe Drinking Water and Toxic Enforcement Act of 1986, ongoing updates)
Requires businesses to provide warnings to Californians about significant exposures to chemicals that cause cancer, birth defects or other reproductive harm, including those found in dietary supplements.
CompanionLabs must identify if any ingredients in their products contain chemicals listed under Proposition 65 and, if so, provide clear warnings on product labels for consumers in California, potentially impacting product perception and formulation choices.
Transform Your Ideas into Action in Minutes with WaxWing
Sign up now and unleash the power of AI for your business growth
